Psoriasis and Psoriatic Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Insights to improve your psoriasis care plan - ModernMedicine



Insights to improve your psoriasis care plan 
ModernMedicine
Some biologics that have been approved to treat psoriasis are also approved by the U.S. Food and Drug Administration to treat inflammatory bowel disease. TNF-alpha blockers infliximab (Remicade, Janssen) and adalimumab (Humira, Abbvie) have been shown ...

and more » 


UCB Advances Psoriasis Pipeline with Positive Data at American Academy of Dermatology Annual Meeting (AAD 2018) - PR Newswire (press release)



UCB Advances Psoriasis Pipeline with Positive Data at American Academy of Dermatology Annual Meeting (AAD 2018) 
PR Newswire (press release)
We are committed to patients with psoriatic disease, through investment in underserved areas and breakthrough solutions that deliver unique outcomes," said Emmanuel Caeymaex, Head of Immunology and Executive Vice President at UCB. "As our research at ...

and more » 


Immune Modulation in the Spotlight at AAD 2018 - Medscape



Medscape
 
Immune Modulation in the Spotlight at AAD 2018 
Medscape
Researchers from AbbVie will present two phase 3 trials of risankizumab for moderate to severe plaque psoriasis. Risankizumab blocks interleukin (IL)-23, a key cytokine linked to chronic immune-mediated diseases, such as Crohn's disease, psoriatic ...

 


Pediatric psoriasis guidelines | Dermatology Times - ModernMedicine



ModernMedicine
 
Pediatric psoriasis guidelines | Dermatology Times 
ModernMedicine
A multi-specialty panel of physician experts has released the first comorbidity screening guidelines for pediatric psoriasis. The consensus statement, released last July, comes out amid increasing evidence that ? like adults with psoriasis ? children ...

and more » 


Pediatric Psoriasis Guidelines - MedPage Today



Pediatric Psoriasis Guidelines 
MedPage Today
The consensus statement, released last July, comes out amid increasing evidence that -- like adults with psoriasis -- children with the disease are at elevated risk for systemic and behavioral comorbidities. "There is increasing evidence that psoriasis ...

 


Psoriatic Arthritis And Stem Cell Therapy - Checkbiotech.org (press release)



Checkbiotech.org (press release)
 
Psoriatic Arthritis And Stem Cell Therapy 
Checkbiotech.org (press release)
Psoriatic arthritis is a chronic inflammatory disease in that occurs in individuals that are affected by autoimmune disease psoriasis. Psoriasis is a condition in which there are red patches on the skin with a silvery layer that looks like scales on ...

 


New Data Demonstrates Long-Term Skin Clearance in Patients with ... - Business Wire (press release)



Business Wire (press release)
 
New Data Demonstrates Long-Term Skin Clearance in Patients with ... 
Business Wire (press release)
SAN DIEGO, Calif.--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA® (guselkumab), who achieved at ...

and more » 


Pediatric dermatology updates - ModernMedicine



Pediatric dermatology updates 
ModernMedicine
Ustekinumab (Stelara, Janssen), an IL-12 and IL-23 inhibitor, which requires injections only four times a year, was approved in October 2017 for pediatric psoriasis patients 12 years of age and older. The approval of these biologic agents significantly ...

 


AbbVie Showcases New, Late-Breaking Investigational Data at 2018 American Academy of Dermatology (AAD) Annual ... - PR Newswire (press release)



registrarjournal.com
 
AbbVie Showcases New, Late-Breaking Investigational Data at 2018 American Academy of Dermatology (AAD) Annual ... 
PR Newswire (press release)
Risankizumab is an investigational compound that selectively blocks IL-23 by binding to its p19 subunit.2 IL-23, a cytokine involved in inflammatory processes, is thought to be linked to a number of chronic immune-mediated diseases.3 Phase 3 trials of ...
These 3 Drugs Are Critical to AbbVie's Success Motley Fool
Financial Newsletter - Zacks Zacks
Abbvie Inc. - ABBV - Stock Price Today - Zacks Zacks
SEC.gov 
all 213 news articles » 


Impact of red and processed meat and fibre intake on treatment ... - DG News



Impact of red and processed meat and fibre intake on treatment ... 
DG News
INTRODUCTION Chronic inflammatory diseases (CIDs) are frequently treated with biological medications, specifically tumour necrosis factor inhibitors (TNFi)

and more »